Ron S Broide is a notable inventor based in San Marcos, California. He has made significant contributions to the field of biotechnology, particularly in the detection of specific proteins and the development of pharmaceutical formulations. With a total of two patents to his name, Broide's work has implications for both research and clinical applications.

Latest Patents

Broide's latest patents include a method for detecting cleaved SNAP25 in tissue samples. This invention describes methods and compositions for detecting BoNT/A enzymatic activity in tissues or tissue samples. The invention encompasses antibodies that bind preferentially to BoNT/A cleaved SNAP25, allowing for the detection of this specific form of the protein compared to intact (non-cleaved) SNAP25 in a tissue sample. Another significant patent involves formulations of biologics for intravesical instillation. This patent discloses pharmaceutical formulations comprising a clostridial derivative and a permeabilizing agent for intravesical instillation.

Career Highlights

Ron S Broide is currently associated with Allergan, Inc., a company known for its focus on developing innovative pharmaceuticals. His work at Allergan has allowed him to contribute to advancements in medical treatments and diagnostics.

Collaborations

Throughout his career, Broide has collaborated with notable colleagues, including Joseph Francis and Ester Fernandez-Salas. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Ron S Broide's contributions to biotechnology through his patents reflect his innovative spirit and dedication to advancing medical science. His work continues to influence the fields of diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.